Ginkgo Bioworks Holdings, Inc.

DNA

NYSE

Healthcare

Biotechnology

Boston, MA, US834 employeesginkgobioworks.com

$6.93

+0.14(2.14%)

Mkt Cap $429M

$5.48

$16.14

52-Week Range

At a Glance

AI-generated

Revenue breakdown: Cell Engineering Revenue (53.2%), Service (40%), Product (6.8%).

8-K

Ginkgo Bioworks Holdings, Inc. announced that its wholly owned subsidiary, Ginkgo Bioworks, Inc., entered into a Stock Purchase Agreement dated February 26, 2026, with Tower Biosecurity, Inc. to contribute all equity interests in Ginkgo Biosecurity, LLC, representing substantially all of the Company's Biosecurity segment operations, in exchange for approximately 20% of Tower Biosecurity's issued and outstanding equity on a fully diluted basis.

$429M

Market Cap

$190M

Revenue

-$349M

Net Income

Employees834

Fundamentals

How The Business Makes Money

Revenue by Segment

Cell Engineering Revenue53.2%($450M)

Service40%($339M)

Product6.8%($58M)

Activity

What Changed Recently

Material Agreement

Feb 26, 2026

. Entry into a Material Definitive Agreement. On February 26, 2026, Ginkgo Bioworks, Inc. (the “Seller”), a wholly owned subsidiary Ginkgo Bioworks Holdings, In

Financial Results

Feb 25, 2026

. Results of Operations and Financial Condition. On February 26, 2026, Ginkgo Bioworks Holdings, Inc. issued a press release announcing its financial results fo

Peer Companies

Company	Price	Change	Market Cap	P/E
VIRVir Biotechnology, Inc.	$9.04	+0.28%	$1.4B	-2.8
IOVAIovance Biotherapeutics, ...	$3.43	-0.58%	$1.1B	-3.8
MBXMBX Biosciences, Inc. Com...	$33.18	+2.76%	$1.1B	-11.8
AVBPArriVent BioPharma, Inc. ...	$24.68	+1.90%	$1.1B	-5.1
MRVIMaravai LifeSciences Hold...	$2.96	+2.96%	$812M	-3.4
MGTXMeiraGTx Holdings plc	$9.18	+0.94%	$739M	-3.7
ATXSATXS	$12.58	+0.00%	$718M	—
ARVNArvinas, Inc.	$10.83	-4.41%	$696M	-8.3

Analyst View

Company Profile

CIK0001830214

ISINUS37611X2099

CUSIP37611X209

Phone877 422 5362

Address27 Drydock Avenue, Boston, MA, 02210, US

SEC EDGAR